CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice
CC趋化因子受体2缺乏可减轻小鼠心肌缺血再灌注引起的氧化应激和梗死面积
基本信息
- 批准号:17590752
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Monocyte chemoattractant protein-1 (MCP-1) belongs to the CC chemokine subfamily with two adjacent cysteine residues and serves as a chemotactic and activating factor for the recruitment of monocytes. CC chemokine receptor 2 (CCR2) is a major receptor for MCP-1 and MCP-1 appears bind solely to CCR2. The purpose of the present study was to investigate the relationship between the monocytic inflammatory response and myocardial ischemia-reperfusion injury by using mice deficient in the CCR2 gene. Experiments were performed in CCR2^<-/-> and wild-type mice subjected to 45 minutes of left coronary artery occlusion followed by reperfusion. Animals were sacrificed at 6 h and at 1, 3, and 7 days after reperfusion. Macrophage infiltration was gradually increased and peaked at 3 days after reperfusion in wild-type mice. However, this process was markedly reduced in CCR2^<-/-> mice (P<0.01). Infarct size was significantly reduced in CCR2^<-/->mice compared with wild-type mice at 3 days after repe … More rfusion (P<0.001). To determine the effect of macrophage infiltration on myocardial fibrosis, we assayed hydroxyproline to quantitate collagen content at 7 days after reperfusion. The hydroxyproline assay revealed that in both groups the collagen content was increased significantly in ischemic myocardium at 7 days after reperfusion compared with non-ischemic or sham-operated myocardium. Collagen content was also significantly greater in ischemic myocardium of wild-type mice compared with CCR2^<-/-> mice (0.92±0.1 μg/mg vs. 0.54±0.1 μg/mg, respectively; P<0.01). In situ zymography revealed augmented gelatinolytic activity at 3 days after reperfusion in wild-type mice, but significantly less activity in CCR2^<-/-> mice. NADPH oxidase activity, the intensity of nitrotyrosine staining and expression of inducible nitric oxide synthase and thioredoxin-1 were significantly decreased in ischemic myocardium in CCR^<-/-> mice compared with wild-type mice. These results suggest that the blockade of CCR2 signaling attenuates oxidative stress and myocardial injury after ischemia-reperfusion. Less
单核细胞趋化蛋白-1(MCP-1)属于CC趋化因子亚家族,具有两个相邻的半胱氨酸残基,并作为单核细胞募集的趋化和活化因子。CC趋化因子受体2(CCR 2)是MCP-1的主要受体,MCP-1似乎仅与CCR 2结合。本研究的目的是通过CCR 2基因缺陷小鼠研究单核细胞炎症反应与心肌缺血再灌注损伤的关系。实验在经历45分钟左冠状动脉闭塞然后再灌注的CCR 2 ^<-/->和野生型小鼠中进行。再灌注后6 h、1、3、7 d处死动物。在野生型小鼠中,巨噬细胞浸润逐渐增加,并在再灌注后3天达到峰值。然而,在CCR 2 ^<-/->小鼠中,该过程显著减少(P<0.01)。与野生型小鼠相比,CCR 2 ^<-/->小鼠在重复给药后3天, ...更多信息 灌流组与对照组比较差异有显著性(P<0.001)。为了确定巨噬细胞浸润对心肌纤维化的影响,我们在再灌注后7天测定羟脯氨酸以定量胶原含量。羟脯氨酸含量测定显示,两组缺血心肌再灌注后7天胶原含量均明显高于非缺血或假手术心肌。野生型小鼠缺血心肌中的胶原含量也显著高于CCR 2 ^<-/->小鼠(分别为0.92±0.1 μg/mg vs. 0.54±0.1 μg/mg; P<0.01)。原位酶谱显示野生型小鼠再灌注后3天明胶分解活性增强,但CCR 2 ^<-/->小鼠的活性显著降低。与野生型小鼠相比,CCR^<-/->小鼠缺血心肌中NADPH氧化酶活性、硝基酪氨酸染色强度以及诱导型一氧化氮合酶和硫氧还蛋白-1的表达显著降低。这些结果表明,阻断CCR 2信号传导可减轻缺血再灌注后的氧化应激和心肌损伤。少
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction
- DOI:10.1111/j.1538-7836.2006.02161.x
- 发表时间:2006-11-01
- 期刊:
- 影响因子:10.4
- 作者:Kaikita, K.;Soejima, K.;Ogawa, H.
- 通讯作者:Ogawa, H.
Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction
- DOI:10.1161/circulationaha.106.671198
- 发表时间:2007-04-10
- 期刊:
- 影响因子:37.8
- 作者:Tsujita, Kenichi;Kaikita, Koichi;Takeya, Motohiro
- 通讯作者:Takeya, Motohiro
MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production I.
MCP-1/CCR2 信号通路通过一氧化氮的产生调节高氧诱导的急性肺损伤 I。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Makino N;Maeda T;Sugano M;Satoh S;Watanabe R;Abe N;Tsujita K.;Hayasaki T;Kaikita K;Okuma T.
- 通讯作者:Okuma T.
MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production
- DOI:10.1111/j.1365-2613.2006.00502.x
- 发表时间:2006-12-01
- 期刊:
- 影响因子:3
- 作者:Okuma, Toshiyuki;Terasaki, Yasuhiro;Takeya, Motohiro
- 通讯作者:Takeya, Motohiro
CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice
- DOI:10.1253/circj.70.342
- 发表时间:2006-03-01
- 期刊:
- 影响因子:3.3
- 作者:Hayasaki, T;Kaikita, K;Takeya, M
- 通讯作者:Takeya, M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAIKITA Koichi其他文献
KAIKITA Koichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAIKITA Koichi', 18)}}的其他基金
Establishment of optimal antithrombotic therapy by using novel thrombus formation analysis system in patients with cardiovascular disease
利用新型血栓形成分析系统为心血管疾病患者建立最佳抗血栓治疗
- 批准号:
15K09089 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid detection of CYP2C19 reduced-function gene polymorphism and the establishment of optimal medical therapy in patients with acute coronary syndrome
急性冠脉综合征患者CYP2C19功能低下基因多态性的快速检测及最佳药物治疗的建立
- 批准号:
24591062 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Serial changes in platelet activation biomarkers and the effects of anti-platelet therapy in percutaneous coronary intervention
经皮冠状动脉介入治疗中血小板活化生物标志物的系列变化及抗血小板治疗的效果
- 批准号:
21590903 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
CCL2/CCR2介导DRG“单核巨噬细胞-痛觉
神经元 ”交互作用调控疱疹神经痛发生
的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
CCL2/CCR2轴介导的星胶-小胶细胞激抑失衡研究利多卡因在瑞芬太尼痛觉过敏中的作用机制
- 批准号:JCZRLH202500309
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
FOS通路介导卵巢冻融移植后MCP-1/CCR2累积致血运重建困难的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
新型CCR2选择性抑制剂通过调控Ca2+/Fe2+通道蛋白MCU表达促进肝癌细胞铁死亡的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于 CCR2/STAT3/CCL2 环路介导的髓系细胞分化探索济生乌梅片干预结直肠癌免疫逃逸的机制
- 批准号:
- 批准年份:2024
- 资助金额:10.0 万元
- 项目类别:省市级项目
DNA碱基配对启发的自修复水凝胶负载Exo@Cur 通
过 CCL2/CCR2 通路促进穿支皮瓣血供扩展研究
- 批准号:2024JJ5478
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
IFNα通过调控CCL2/CCR2诱导肝内促炎巨噬细胞实现乙肝功能性治愈的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
白芥子通过 CCL2/CCR2轴激活ERK/P38 通路调控Treg/Th 17
细胞抑制肝癌免疫逃逸研究
- 批准号:2024JJ9531
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
枳壳甘草汤通过调控IL-17R信号自主激活介导CCL2/CCR2改善腰椎间盘突出痛敏的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
黄芩苷经“CCL2/CCR2/MAPK/NF-κB信号轴”抑制滑膜成纤维细胞-滑膜巨噬细胞“交叉对话”缓解RA的机制研究
- 批准号:82360802
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Dissecting the Role of Donor CCR2- Macrophages During Acute Cellular Rejection After Heart Transplantation
剖析供体 CCR2-巨噬细胞在心脏移植后急性细胞排斥过程中的作用
- 批准号:
10449753 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Dissecting the Role of Donor CCR2- Macrophages During Acute Cellular Rejection After Heart Transplantation
剖析供体 CCR2-巨噬细胞在心脏移植后急性细胞排斥过程中的作用
- 批准号:
10597230 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
通过阻断多个 CCR2 趋化因子受体表位将巨噬细胞极化为肿瘤抑制因子
- 批准号:
10380283 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
通过阻断多个 CCR2 趋化因子受体表位将巨噬细胞极化为肿瘤抑制因子
- 批准号:
10328882 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
通过阻断多个 CCR2 趋化因子受体表位将巨噬细胞极化为肿瘤抑制因子
- 批准号:
9973323 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
通过阻断多个 CCR2 趋化因子受体表位将巨噬细胞极化为肿瘤抑制因子
- 批准号:
10737843 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
通过阻断多个 CCR2 趋化因子受体表位将巨噬细胞极化为肿瘤抑制因子
- 批准号:
10524148 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Polarizing Macrophages to Tumor Suppressors by Blocking Multiple CCR2 Chemokine Receptor Epitopes
通过阻断多个 CCR2 趋化因子受体表位将巨噬细胞极化为肿瘤抑制因子
- 批准号:
10559551 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
用于胰腺癌成像和预测标准和 CCR2 靶向治疗反应的新型 CCR2 PET
- 批准号:
10534151 - 财政年份:2019
- 资助金额:
$ 2.24万 - 项目类别:
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
用于胰腺癌成像和预测标准和 CCR2 靶向治疗反应的新型 CCR2 PET
- 批准号:
10318589 - 财政年份:2019
- 资助金额:
$ 2.24万 - 项目类别: